EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies

Valentina Pala iD, Francois Rosset iD, Luca Mastorino iD, Nadia Sciamarrelli, Sara Boskovic, Silvia Borriello, Eleonora Bongiovanni iD, Orsola Crespi iD, Simone Ribero iD, Pietro Quaglino

International Journal of Molecular Sciences · 04.11.2025 · 26 (21) · 10720

DOI: 10.3390/ijms262110720 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.11.2025. Verfasst von Valentina Pala und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, School of Dermatology and Venereology, University of Turin, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Th2 Cells, Skin Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T helper 2 (Th2)-mediated dermatoses are inflammatory skin diseases driven by CD4+ Th2 cells that produce interleukin (IL)-4, IL-5, IL-13, and IL-31, promoting immunoglobulin E (IgE) class switching, eosinophil recruitment, mast cell degranulation, and pruritus. We aimed to place these conditions in context and clarify how Th2 biology informs diagnosis and therapy. We conducted a narrative synthesis of mechanistic, translational, and clinical evidence on Th2 pathways in atopic dermatitis (AD), prurigo nodularis, bullous pemphigoid, chronic spontaneous urticaria, and selected type I/IVb hypersensitivity reactions, with focused appraisal of trials targeting IL-4Rα, IL-13, and IL-31R. Persistent Th2 activation is associated with epidermal barrier dysfunction, immune dysregulation, and pruritogenic neural signaling; AD is the archetype, showing prominent lesional IL-4/IL-13 activity correlated with severity and itch. Across disorders, pathway-directed biologics against IL-4Rα, IL-13, and IL-31R consistently reduce disease activity and pruritus in AD and prurigo nodularis, with emerging signals of benefit in bullous pemphigoid and chronic spontaneous urticaria. The Th2 axis provides a unifying pathogenic framework and actionable therapeutic target across multiple dermatoses. Integrating cytokine profiling with clinical phenotypes may refine patient stratification and optimize the deployment of existing and next-generation Th2-targeting therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th2 CellsSkin DiseasesHumansAnimalsMolecular Targeted TherapyDermatitis, Atopic

Stichwörter der Autor:innen

T helper 2 cellsTh2-mediated dermatosesinterleukin-4 (IL-4) and interleukin-13 (IL-13)pruritustargeted biologic therapies

Autor:innen und Institutionen

  • Department of Medical Sciences, School of Dermatology and Venereology, University of Turin, 10126 Turin, Italy.

ORCID-Profile: Valentina Pala, Francois Rosset, Luca Mastorino, Eleonora Bongiovanni, Orsola Crespi, Simone Ribero

Zitieren

APA

Pala, V., Rosset, F., Mastorino, L., Sciamarrelli, N., Boskovic, S., Borriello, S., Bongiovanni, E., Crespi, O., Ribero, S., & Quaglino, P. (2025). The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies. International Journal of Molecular Sciences, 26(21), 10720. https://doi.org/10.3390/ijms262110720

Vancouver

Pala V, Rosset F, Mastorino L, Sciamarrelli N, Boskovic S, Borriello S, et al. The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies. International Journal of Molecular Sciences. 2025;26(21):10720. doi:10.3390/ijms262110720

BibTeX
@article{Pala2025,
  author = {Pala, Valentina and Rosset, Francois and Mastorino, Luca and Sciamarrelli, Nadia and Boskovic, Sara and Borriello, Silvia and Bongiovanni, Eleonora and Crespi, Orsola and Ribero, Simone and Quaglino, Pietro},
  title = {The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10720},
  doi = {10.3390/ijms262110720}
}
Kostenlos starten →